Visual Perception Difficulties After Stroke

Last updated: August 5, 2024
Sponsor: Durham University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Treatment

OxVPS

Clinical Study ID

NCT05981482
Durham University
  • Ages > 18
  • All Genders

Study Summary

The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties.

The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems?

Participants will completed the OxVPS and the current gold standards visual perception screening tool.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebralhaemorrhage).

  • Within 6 weeks of confirmed stroke.

Exclusion

Exclusion Criteria:

  • Insufficient understanding of English

  • Clinical concerns that patient is unable follow simple instructions.

  • Clinical concerns that patient is unable to concentrate for 15 minutes.

  • No capacity to provide informed consent.

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: OxVPS
Phase:
Study Start date:
June 20, 2023
Estimated Completion Date:
February 28, 2026

Study Description

This is a non-experimental cross-sectional study. It aims to compare the new screening test OxVPS to the gold standard tests for visual perception difficulties.

Patients will be recruited at stroke rehabilitation units at hospitals in the North East of England and in Oxfordshire.

Following consent:

  • Participants will complete the paper version of the Oxford Visual Perception Screen OxVPS (~15 min).

  • Participants will complete screening for visual perception problems with a validated screening tool (~30-120 min).

  • Participants will complete screening for cognition alterations and sensory vision with validated screening tools. (~30 min)

  • Stroke details (time since stroke, severity) and demographic data (age, socio-economic status) will be collected to evaluated representativeness of the sample.

Connect with a study center

  • Abingdon Community Hospital

    Abingdon, OX14 1AG
    United Kingdom

    Active - Recruiting

  • Bishop Auckland Hospital

    Bishop Auckland, DL14 6AD
    United Kingdom

    Active - Recruiting

  • Queen Elizabeth Hospital

    Gateshead, NE9 6SX
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.